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Abstract 
Purpose: We conducted a meta-analysis to evaluate and compare the short- and long-term 
results of laparoscopy-assisted colectomy (LAC) and open colectomy (OC) for colon cancer. 
Methods: We searched MEDLINE, EMBASE, Science Citation Index, and Cochrane Con-
trolled Trial Register for relevant papers published between January 1990 and October 2011 
by using the search terms “laparoscopy,” “laparoscopy-assisted,” “surgery,” “colectomy,” 
“colon cancer,” and “randomized clinical trials (RCTs)”. We analyzed the outcomes of each 
type of surgery over short- and long-term periods. 
Results: We selected 12 papers reporting RCTs that compared LAC with OC for colon 
cancer. Our meta-analysis included 4614 patients with colon cancer; of these, 2444 had 
undergone LAC and 2170 had undergone OC. In the short-term period, we found that the 
rates of overall postoperative complications and ileus in LAC were lower than in OC groups. 
LAC was associated with a reduction in intraoperative blood loss, a shorter duration of time 
to resumption and hospital stay, and lower rates of overall complication and ileus over the 
short-term, but with similar long-term oncologic outcomes such as overall and cancer-related 
mortality, overall recurrence, local recurrence, distant metastasis, and wound-site recur-
rence, compared to OC.  
Conclusions: It is suggested that LAC may be preferred to OC for colon cancer. 
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Introduction 
Colon cancer is one of the most common types of 
cancer in developed countries, and surgery is the only 
curative  treatment.  Successful  laparoscopy-assisted 
sigmoidectomy for colon cancer was first described in 
19911 and has since then been widely applied by sur-
geons to treat patients with colon cancer. 
Several  articles  have  reported  the  short-term 
advantages of laparoscopy-assisted colectomy (LAC) 
over  conventional  open  colectomy  (OC)  and  have 
concluded that laparoscopic surgery causes less pain, 
results  in  better  pulmonary  function,  shortens  the 
duration of postoperative ileus, reduces fatigue, and 
offers a better quality of life2-5. However, the benefits 
of  LAC  have  remained  controversial  because  the 
long-term  outcomes  have  not  yet  been  clarified.  To 
accurately evaluate the efficacy of laparoscopic sur-
gery for colon cancer, the short- and long-term out-
comes of laparoscopic surgery must be compared to 
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those  of  open  surgery.  For  short-term  outcomes, 
perioperative  variables,  pathologic  factors,  and  the 
cost  of  surgery  should  be  examined.  For  long-term 
outcomes, long-term oncologic results are the primary 
endpoint  of  interest.  The  long-term  oncologic  out-
comes  of  LAC,  such  as  tumor  recurrence  rate  and 
mortality rate, have been published over time6-9. Sev-
eral  randomized  control  trials  (RCTs)  that  compare 
LAC with OC have been reported  6-25. Therefore, we 
conducted a meta-analysis of the data obtained from 
these RCTs and compared the short- and long-term 
outcomes of LAC and OC by considering several fac-
tors. 
Materials and methods 
Literature search 
To  identify  papers  relevant  to  our  study,  we 
searched through the major medical databases such as 
MEDLINE,  EMBASE,  Science  Citation  Index,  and 
Cochrane Controlled Trial Register for studies pub-
lished between January 1990 and October 2011. The 
following  search  terms  were  used:  “laparoscopy,” 
“laparoscopy-assisted,” “surgery,” “colectomy,” and 
“colon cancer.” Furthermore, we limited our literature 
search  to  randomized  controlled  trials.  We  treated 
studies that were part of a series as a single study. The 
appropriate data from such study series were used for 
this meta-analysis. This meta-analysis was prepared 
in accordance with the Preferred Reporting Items for 
Systematic  Reviews  and  Meta-Analyses  (PRISMA) 
statement26 (Fig.1). 
Inclusion criteria 
To enter this meta-analysis, studies had to: (1) be 
described  in  English  (2)  be  randomized  controlled 
trials (3) compare laparoscopic and open conventional 
surgery for colon cancer (4) report on at least one of 
the outcome measures mentioned below. 
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Data extraction 
Three researchers (H.O., Y.T., and Y.A.) extract-
ed data from each article by using a structured sheet 
and  entered  the  data  into  a  database.  Because  this 
analysis  was  based  on  the  intention-to-treat  princi-
ple27,  all  patients  converted  from  the  laparoscopic 
group  to  the  conventional  open  surgery  group  re-
mained  in  the  laparoscopic  group  for  analysis.  We 
conducted  separate  meta-analyses  for  2  different 
postoperative time periods: short-term and long-term. 
For the short-term analysis, we collected data on op-
eration time, estimated blood loss, number of trans-
fused  patients,  number  of  dissected  lymph  nodes, 
time  to  resumption,  hospital  stay,  incision  length, 
overall  postoperative  complications,  ileus,  anasto-
motic  leakage,  perioperative  mortality,  circumferen-
tial  resection  margin,  oral  resection  margin,  distal 
resection margin, and cost of surgery. We also exam-
ined  the  relationship  between  the  conversion  rate 
from  laparoscopic  to  open  surgery  and  sin-
gle-institution  versus  multicenter  trials.  For  the  on-
cologic results in the long-term analysis, we used data 
on  the  rate  of  overall  recurrence,  local  recurrence, 
distant  metastasis,  peritoneal  dissemination, 
wound-site  recurrence,  overall  mortality,  and  can-
cer-related mortality. If necessary, we contacted the 
authors of the original article to collect further infor-
mation. 
Assessment of study quality  
The quality of the randomized controlled trials 
was  assessed  using  Jadad’s  scoring  system28.  Two 
reviewers (H.O., Y.T.) assessed all studies that met the 
inclusion criteria (Table 1). 
Statistical analysis 
Weighted  mean  differences  (WMDs)  and  odds 
ratios (ORs) were used for the analysis of continuous 
and  dichotomous  variables,  respectively.  Ran-
dom-effects models were used to identify heteroge-
neity between the studies29, and the degree of heter-
ogeneity was assessed using the χ2 test. For the anal-
ysis of the conversion rate, the χ2 test was used. The 
confidence interval (CI) was established at 95%, and p 
values of less than 0.05 were considered to indicate 
statistical significance.  
 
Table 1.  Characteristics of randomized controlled trials. 
authors  Year  country  number 
of refer-
ence 
institutions 
of the study 
Conversion 
rate (%) 
Study size 
(n) 
follow-up 
period  
(months) 
Ran-
domiza-
tion 
Double 
Blinding 
With-
drawals 
and 
dropouts 
Jadad's 
score 
LC  OC 
Braga et al.   2010  Italy  10  single center  5.2(7/134)  134  134  73 months 
(median) 
2  2  1  5 
CLASICC trial 2010, 
2007, 
2005 
UK  6, 7, 13, 
21 
multicenter 
(27) 
25(61/246)  526  268  56.3 months 
(median) 
2  2  1  5 
COLOR trial  2009, 
2005 
Sweden,  
Netherlands, 
Spain, Italy, 
France, UK, 
Germany 
14, 15  multicenter 
(29) 
19(102/534)  534  542  53 months 
(median) 
2  2  1  5 
COST trial  2004  USA and 
Canada 
16, 18  multicenter 
(48) 
21(90/435)  435  428  7 years (medi-
an) 
2  2  1  5 
Curet et al.  2000  USA  17  single center  28(7/25)  25  18  4.9 years 
(mean) 
2  2  1  5 
ALCCaS trial 
(Hewett et al.) 
2008  Australia and 
New Zealand 
24  multicenter 
(31)  
14.6(43/294)  294  298  unknown  2  0  1  3 
Kaiser et al.  2004  USA  22  single center  46.4(13/28)  28  20  35 months 
(median) 
2  0  1  3 
Barcelona trial 
(Lacy et al.) 
2008  Spain  8, 9  single center  11(12/111)  111  108  95 months 
(median) 
2  2  1  5 
Liang at al.  2006  Taiwan  19  single center  3(4/135)  135  134  40 months 
(median) 
2  2  1  5 
Mirza et al.  2008  UK  20  single center  17 (19/113) 
concluding 
rectal cancer 
116  117  48 months 
(median) 
1  0  0  1 
Pascual et al.   2011  Spain  23  single center  12(7/60)  60  60  41 months 
(median) 
2  2  1  5 
Winslow et al  2002  USA  25  single center  15(7/46)  46  43  30.1 months 
(mean) 
2  0  1  3 
UK: United Kingdom, US: United States of America 
  Journal of Cancer 2012, 3 
 
http://www.jcancer.org 
52 
As the cost data of 1 article21 were precious and 
had neither a range nor any other measure of disper-
sion, the  standard deviation (SD) was estimated by 
halving the mean30. One Euro and British pound were 
converted to 1.4 and 1.6 US dollars, respectively. Sta-
tistical  analyses  were  performed  using  the  Review 
Manager  (RevMan)  software  version  5.1.4  provided 
by  the  Cochrane  Collaboration,  Copenhagen,  Den-
mark.  
Results 
We identified 12 RCTs that compared LAC and 
OC  for  colon  cancer6-25.  The  characteristics  of  each 
RCT are presented in Table 1. Our meta-analysis in-
cluded 4614 patients with colon cancer; of these, 2444 
had undergone LAC, and 2170, OC. The results of the 
outcomes  over  short-  and  long-term  periods  are 
shown in Fig. 2 and Fig. 3, respectively.  
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Fig. 2 Meta-analysis of the short-term period for colon cancer   Journal of Cancer 2012, 3 
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Fig. 3 Meta-analysis of the long- term oncologic results for colon cancer 
 
Short-term outcomes 
Of the 12 RCTs, 5 reported the operative dura-
tion; in all 5 reports, the operative duration was sig-
nificantly longer for LAC than for OC. Our analysis 
showed that the operative duration for LAC was sig-
nificantly longer than that for OC by 42.08 min (WMD 
= 42.08; 95% CI = 29.87 to 54.30; p < 0.00001). Blood 
loss in patients who underwent LAC was significantly 
lesser than that in patients who underwent OC, by an 
average volume of 103.9 ml (WMD = -103.90; 95% CI = 
-180.88 to -26.91; p = 0.008). There was no significant 
difference in the number of transfused patients. We 
found no significant difference in the number of dis-
sected  lymph  nodes  between  LAC  and  OC  groups. 
The duration of hospital stay and the time to oral diet 
were significantly shorter with LAC than with OC (p 
= 0.01 and < 0.00001, respectively). The incision length 
was significantly shorter by 11.77 cm in LAC than in 
OC. The rate of the overall postoperative complica-
tions was significantly lower in LAC than in OC (OR 
= 0.73; 95% CI =0.56 to 0.95; p = 0.02). In examining 
the details of them, we found that the rate of ileus was 
significantly lower in LAC than in OC (OR = 0.40; 95% 
CI =0.25 to 0.66; p = 0.0003). The rate of anastomotic 
leakage between the 2 groups was insignificant. We 
also found no significant differences in perioperative 
mortality between the 2 groups when we pooled the 
data for LAC and OC for colon cancer. 
Pathological factors 
In  an  analysis  of  pooled  data,  we  found  that 
there was no significant difference in the circumfer-
ential resection margin between the 2 groups. There 
was  no  significant  difference  in  the  oral  and  distal 
resection margin. 
Cost of surgery 
In an analysis of the total cost of surgery, there 
was no significant difference between the 2 groups.  
Conversion rate 
Twelve articles reported data on the conversion 
rate from laparoscopic to open surgery, which ranged 
from 3 to 46.4% (Table 1). In an analysis of the con-
version rate, there  was no significant difference be-
tween the trials performed by a single institution and 
those performed on a multicenter basis (p = 0.31). 
Long-term outcomes 
With respect to  overall recurrence, local recur-
rence,  distant  metastasis,  and  peritoneal  dissemina-
tion, the differences between the 2 groups were in-
significant. Our analysis of the wound-site recurrence 
between the LAC and OC groups indicated no signif- Journal of Cancer 2012, 3 
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icant difference. There was also no significant differ-
ence  in  the  overall  and  cancer-related  mortality  be-
tween the 2 groups.   
Heterogeneity 
In the short-term period, significant heterogene-
ity was detected between studies for the following 6 
factors: operative time, intraoperative blood loss, du-
ration of hospital stay, incision length, overall post-
operative complications, and cost of surgery. In the 
long-term  periods,  no  significant  heterogeneity  was 
detected between studies. 
Discussion 
In short-term periods, laparoscopic surgery for 
colon cancer is associated with a significantly longer 
operative  time,  but  significantly  less  intraoperative 
blood loss compared with conventional open surgery. 
These results are consistent with those of recent ran-
domized controlled trials 8,13,15. Potential explanations 
for  the  abovementioned  results  include  meticulous 
dissection facilitated by instruments for laparoscopic 
surgery and videoscopic magnification. The similarity 
of oncological outcomes such as circumferential, oral, 
and distal resection margin and the number of har-
vested lymph nodes between the 2 groups indicates 
identical quality of the operative techniques. Patients 
who  underwent  LAC  resumed  oral  intake  signifi-
cantly  earlier  and  had  significantly  shorter  hospital 
stays  than  did  patients  who  underwent  OC;  this 
finding  suggests  that  LAC  leads  to  faster  recovery. 
The rate of postoperative complications was signifi-
cantly lower in LAC than on OC. In examining the 
details, we found the rate of ileus significantly lower 
in LAC than in OC. Gutt et al. describe that laparo-
scopic surgery reduces adhesion formation compared 
with open surgery. Because laparoscopic procedures 
reduce the overall degree of trauma to the abdominal 
wall,  intraabdominal  operative  site,  and  distant  in-
traabdominal  organs,  they  potentially  have  an  ad-
vantage  in  reducing  the  formation  of  postoperative 
adhesion31.  The  abovementioned  suggests  that  LAC 
may be safer and more feasible than OC.  
In the analysis of the total cost of surgery, we 
found no significant overall difference between LAC 
and  OC.  However,  the  operating  costs  were  higher 
and  the  hospitalization  costs  were  lower  for  LAC 
compared with OC. 
Several reports have shown that conversion from 
laparoscopic to open surgery is associated with infe-
rior surgical outcomes6. In this analysis, the conver-
sion rate was not significantly related to the type of 
study,  i.e.,  single-institution  or  multicenter.  The 
CLASICC  trial  reported  that  tumor  infiltra-
tion/fixation  and  obesity  were  the  most  common 
reason for conversion13.  
In the long-term period, we found no significant 
difference in overall recurrence, local recurrence, dis-
tant metastasis, and peritoneal dissemination between 
the 2 surgery groups. There was also no significant 
difference  in  wound-site  recurrence  between  the  2 
groups. No significant difference was found in overall 
and  cancer-related  mortality.  The  abovementioned 
findings suggest that LAC is comparable to OC with 
respect to long-term oncologic results. Lacy et al. re-
ported  that  there  was  a  tendency  of  higher  can-
cer-related  and  overall  survival  for  LAC9,  but  our 
meta-analysis  of the pooled data did not show this 
difference. 
Significant  heterogeneity  was  observed  for  op-
erative  time,  intraoperative  blood  loss,  duration  of 
hospital  stay,  incision  length,  overall  postoperative 
complications, and cost of surgery in the short-term 
period. The reason for the observed heterogeneity in 
operative time, intraoperative blood loss, and overall 
postoperative complications may be variations in the 
skill of the surgeon and the condition of the tumor. 
Differences in the clinical approach at different insti-
tutions may have caused the heterogeneity in the du-
ration of hospital stay and incision length. Significant 
heterogeneity for cost of surgery may be caused by 
differences in medical fees among countries. 
In  conclusion,  this  meta-analysis  showed  that 
laparoscopic  surgery  for  colon  cancer  is  associated 
with a reduction in intraoperative blood loss, earlier 
resumption of oral intake, shorter duration of hospital 
stay,  and  rate  of  postoperative  complications  con-
cluding  ileus  over  the  short-term,  but  is  associated 
with similar short-term and long-term oncologic out-
comes  compared  to  conventional  open  surgery. 
Therefore,  it  is  suggested  that  laparoscopic  surgery 
may  be  preferred  to  conventional  open  surgery  for 
colon cancer. 
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